|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT03354533 |
|
Date of registration:
|
21/11/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type II
|
|
Scientific title:
|
Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type II |
|
Date of first enrolment:
|
January 1, 2012 |
|
Target sample size:
|
4 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03354533 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
|
Phase:
|
Phase 1/Phase 2
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Diagnosis of Leukocyte Adhesion Deficiency Type II.
- Less than 18 years old.
Exclusion Criteria:
- Diagnosis of any other disease that is not a manifestation of Leukocyte Adhesion
Deficiency Type II.
Age minimum:
N/A
Age maximum:
18 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Leukocyte Adhesion Deficiency, Type II
|
|
Intervention(s)
|
|
Drug: L-fucose
|
|
Primary Outcome(s)
|
|
Decrease in infection frequency
[Time Frame: 12 months after treatment started]
|
|
Secondary Outcome(s)
|
|
Decrease in neutrophil count
[Time Frame: 30 days after treatment started]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|